CBD: A New Hope?

UNCG Author/Contributor (non-UNCG co-authors, if there are any, appear on document)
Patricia H. Reggio, Professor and Department Head (Creator)
The University of North Carolina at Greensboro (UNCG )
Web Site: http://library.uncg.edu/

Abstract: The nonpsychoactive phytocannabinoid, CBD, was recently approved by the Food and Drug Administration for the treatment of children with drug-resistant epilepsy. This milestone opens new avenues for cannabinoid research. In this Viewpoint, we provide an overview of recent progress in the field highlighting molecular insights into CBD’s mechanism of action, as well as its therapeutic potential.

Additional Information

ACS Medicinal Chemistry Letters 2019, 10, 5, 694-695
Language: English
Date: 2019
Cannabidiol, phytocannabinoids, epilepsy, CB1, CB2, GPCRs

Email this document to